Clin2
NCT02845531Possibly a fitRecruiting

Defibrillator device vs medicines for a rare heart spasm after arrest

Angina Pectoris, VariantSudden Cardiac Death

Treatments studied

Part of Heart & circulation, Pain clinical trials.

This trial compares an implantable defibrillator device plus best care versus best medicines alone in people who survived a cardiac arrest caused by a specific abnormal heart rhythm. It focuses on variant angina, where a heart-spasm problem can trigger dangerous rhythm events, to see which approach prevents future events.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
140 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are age 18 or older.
  • You survived (were successfully resuscitated from) a cardiac arrest caused by ventricular fibrillation or sustained fast ventricular tachycardia.
  • Your doctors diagnosed variant angina from evidence of a coronary (heart blood vessel) spasm on tests.
  • You do NOT have major (more than 50%) blockage in the heart arteries on angiogram testing.
  • You have not previously had a pacemaker or an implantable defibrillator, and you have not had prior catheter ablation for a dangerous rhythm.
  • You do not have certain heart muscle/electrical conditions, severe heart failure symptoms (NYHA class III/IV), or a limited life expectancy (less than 2 years).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05665608Recruiting
Prevent sudden death after a heart attack with a defibrillator

This trial studies whether implanting a defibrillator (ICD) soon after a heart attack can lower the risk of sudden cardiac death in people with weaker heart pumping and symptoms of heart failure. It compares strategies around defibrillator implantation, aiming to improve safety and outcomes.

Feldkirch
NCT07415642Not yet recruiting
Medication and defibrillators for non-ischemic cardiomyopathy

This study compares modern heart failure medications and implantable cardioverter-defibrillators (ICDs) to reduce the risk of sudden cardiac death in people with a specific type of heart muscle disease (non-ischemic cardiomyopathy) that is not caused by blocked arteries. It may help guide treatment decisions for those with a weakened heart and certain scarring on heart MRI.

Groningen
NCT03588286Recruiting
Check heart rhythm risk early after a heart attack

This trial tests whether a programmed heart rhythm test can better identify who needs an implanted defibrillator (ICD) soon after a heart attack. It may help prevent dangerous fast heart rhythms (tachyarrhythmias) by guiding who gets an ICD.

Boston, Massachusetts
NCT06269692Not yet recruiting
MRI-guided defibrillator implant for weak heart pumping

This trial tests whether using an MRI to help place a defibrillator (a device that corrects dangerous heart rhythms) works better than the usual method. It may help people with weak heart pumping after a heart attack.

Vandœuvre-lès-Nancy
NCT04576130Recruiting
ICD study after cardiac arrest from an abnormal heart rhythm

This study looks at an implantable defibrillator (ICD) strategy in people who survived a cardiac arrest caused by an abnormal rhythm (ventricular fibrillation or ventricular tachycardia). It aims to reduce the risk of another dangerous rhythm after the blocked heart arteries are fully treated.

Copenhagen
NCT06835491Recruiting· Phase 3
Amiodarone to prevent heart rhythm problems after cardiac arrest

This trial tests whether giving the drug amiodarone early can prevent dangerous heart rhythm problems in patients who survived a cardiac arrest with a shockable rhythm. If it works, it could help more people recover.

Amiens

Hear when a new Sudden Cardiac Death trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.